AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Grace Therapeutics, Inc.
$1.94
-$1.72 (-46.99%)
Previous Close
$1.94
Day Range
$1.87$1.98
Year Range
$1.67$5.18
Market Cap
31.57M
AVG Volume
178.38K
Trailing/Forward PE
-1.54/-
PEG ratio
0.08
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: GRCE
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.
Video analysis: GRCE
All videosNo video analysis for this stock yet. Request one from our team.
News: GRCE
Similar companies
-
Tvardi Therapeutics, Inc.
TVRD
·
NASDAQ
Compare
-
Actinium Pharmaceuticals, Inc.
ATNM
·
New York Stock Exchange Arca
Compare
-
PDS Biotechnology Corporation
PDSB
·
NASDAQ
Compare
-
CalciMedica, Inc.
CALC
·
NASDAQ
Compare
-
Xilio Therapeutics, Inc.
XLO
·
NASDAQ
Compare
-
Lantern Pharma Inc.
LTRN
·
NASDAQ
Compare